Besides its expression on immune cells, TIM-3 has been found in AML leukemia stem cells but not in their normal counterparts (51, 52), and increased levels of Galectin- 9, a TIM-3 ligand, were found in AML patients’ serum (53). This evidence concerns the gene LGALS9 and leukemia.